OSX — Osteopore Share Price
0.000.00%
Last trade - 00:00- AU$1.99m
- AU$2.68m
- AU$2.76m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.48 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.72 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -707.36% | ||
| Return on Equity | -907.51% | ||
| Operating Margin | -106.51% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 1.5 | 1.11 | 1.69 | 2.22 | 2.76 | n/a | n/a | 46.34% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Osteopore Limited is an Australia-based regenerative medicine company engaged in three-dimensional (3D)-printed biomimetic and bioresorbable implants. The Company seeks to commercialize products that stimulate natural bone healing across multiple segments. It creates patented scaffolds using 3D-printed biomimetic and bioresorbable materials to guide and nurture bone-forming cells. Through its proprietary manufacturing process, which uses a naturally dissolving polymer, its patented scaffolds enable bone tissue growth, significantly reducing the post-surgery complications commonly associated with permanent bone implants. The Company’s surgical specialty includes craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, and immediate implant loading, among others.
Directors
- Brett Sandercock NEC (54)
- Khoon Seng Goh CEO
- Carl Runde CFO
- Lim Jing CTO
- Deborah Ho SEC
- Teoh Swee Hin NED
- Vlado Bosanac NID
- Daniel Ow NID
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 11th, 2018
- Public Since
- September 23rd, 2019
- No. of Shareholders
- 2,216
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 116,801,137
- Address
- Ground Floor, 16 Ord St, Perth, 6005
- Web
- https://www.osteopore.com/
- Phone
- +61 280721400
- Auditors
- Grant Thornton Audit Pty Ltd
Upcoming Events for OSX
Osteopore Ltd Annual Shareholders Meeting
Half Year 2025 Osteopore Ltd Earnings Release
Similar to OSX
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
What is the Osteopore share price?
As of Today at 22:29 UTC, shares in Osteopore are trading at AU$0.02. This share price information is delayed by 15 minutes.
How has the Osteopore share price performed this year?
Shares in Osteopore last closed at AU$0.02 and the price had moved by -95.75% over the past 365 days. In terms of relative price strength the Osteopore share price has underperformed the ASX All Ordinaries Index by -95.9% over the past year.
What are the analyst and broker recommendations for Osteopore?
There is no consensus recommendation for this security.
Find out moreWhat is the Osteopore dividend yield?
Osteopore does not currently pay a dividend.
Does Osteopore pay a dividend?
Osteopore does not currently pay a dividend.
When does Osteopore next pay dividends?
Osteopore does not currently pay a dividend.
How do I buy Osteopore shares?
To buy shares in Osteopore you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Osteopore?
As of the previous close price of AU$0.02, shares in Osteopore had a market capitalisation of AU$1.99m.
Where are Osteopore shares listed?
Here are the trading details for Osteopore:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: OSX
What kind of share is Osteopore?
Based on an overall assessment of its quality, value and momentum Osteopore is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Osteopore share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Osteopore share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Osteopore. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -57.35%.
As of the last closing price of AU$0.02, shares in Osteopore were trading -54.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Osteopore PE Ratio?
The Osteopore PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Osteopore?
Osteopore's management team is headed by:
- Brett Sandercock - NEC
- Khoon Seng Goh - CEO
- Carl Runde - CFO
- Lim Jing - CTO
- Deborah Ho - SEC
- Teoh Swee Hin - NED
- Vlado Bosanac - NID
- Daniel Ow - NID